GSA Capital Partners’s Strata Critical Medical Inc SRTA Stock Holding History

GSA Capital Partners’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-147,449	Closed	-$403K	–	1758
2025 Q1	$403K	Sell	147,449 -166,071	-53%	-$596K	0.04%	947
2024 Q4	$1.33M	Sell	313,520 -64,720	-17%	-$246K	0.1%	238
2024 Q3	$1.11M	Buy	378,240 +268,802	+246%	+$856K	0.08%	409
2024 Q2	$381K	Sell	109,438 -174,286	-61%	-$581K	0.03%	1137
2024 Q1	$809K	Buy	283,724 +119,410	+73%	+$368K	0.06%	583
2023 Q4	$580K	Buy	+164,314	New	+$472K	0.05%	695
2023 Q1	–	Sell	-53,226	Closed	-$191K	–	1498
2022 Q4	$191K	Buy	+53,226	New	+$227K	0.02%	1196

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GSA Capital Partners's SRTA Position: Q2 2025 in Review

GSA Capital Partners sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 147,449 shares — an estimated $403K sold.

GSA Capital Partners first reported a position in SRTA in Q4 2022 and held it in 7 quarters. The position peaked at $1.33M in Q4 2024. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

GSA Capital Partners reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
GSA Capital Partners sold 147,449 Strata Critical Medical Inc shares in Q2 2025, an estimated $403K.
GSA Capital Partners first reported a position in Strata Critical Medical Inc in Q4 2022 and held it in 7 quarters.
GSA Capital Partners's Strata Critical Medical Inc position peaked at $1.33M in Q4 2024.
126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.